Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease

Health and Quality of Life Outcomes

Volumn 1, Issue , 2003, Pages

  Shahriar, Jim ^a   Delate, Thomas ^b   Hays, Ron D ^c   Coons, Stephen Joel ^d  

^a Quality Programs   (United States)

^b Express Scripts   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DETERIORATION; EVIDENCE BASED MEDICINE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; INTERMETHOD COMPARISON; MEASUREMENT; MEDICAL INFORMATION SYSTEM; MEDICAL LITERATURE; MEDICAL PRACTICE; PHYSICAL CAPACITY; POPULATION RESEARCH; PUBLISHING; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SOCIAL LIFE; UNITED STATES; VALIDATION PROCESS; COMPARATIVE STUDY; FEMALE; HEALTH SURVEY; INSTRUMENTATION; MALE; METHODOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REPRODUCIBILITY;

FEMALE; HEALTH STATUS; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0348052077     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-1-25     Document Type: Article

References (81)

1. Hays RD and Shapiro MF: An overview of generic health-related quality of life measures for HIV research Qual Life Res 1992, 1(2):91-97.
2. de Boer JB, van Dam FS and Sprangers MA: Health-related quality-of-life evaluation in HIV-infected patients. A review of the literature Pharmacoeconomics 1995, 8(4):291-304.
3. Paltiel AD and Stinnett AA: AIDS Quality of life and pharmacoeconomics in clinical trials Edited by: Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:1053-1062.
4. Berzon RA and Lenderking WR: Evaluating the outcomes of HIV disease: focus on health status measurement Medical Outcomes Trust Monitor 1998, 3:1-8.
5. Torres RA and Barr M: Impact of combination therapy for HIV infection on inpatient census N Engl J Med 1997, 336(21):1531-1532.
6. Hirschel B and Francioli P: Progress and problems in the fight against AIDS N Engl J Med 1998, 338(13):906-908.
7. Bozzette SA, Hays RD, Berry SH and Kanouse DE: A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity Med Care 1994, 32(7):716-731.
8. Davis EA and Pathak DS: Psychometric evaluation of four HIV disease-specific quality-of-life instruments Ann Pharmacother 2001, 35(5):546-552.
9. Stewart AL, Hays RD and Ware JE Jr: The MOS short-form general health survey. Reliability and validity in a patient population Med Care 1988, 26(7):724-735.
10. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E and Zubkoff M: The Medical Outcomes Study. An application of methods for monitoring the results of medical care JAMA 1989, 262(7):925-930.
11. Wu AW, Hays RD, Kelly S, Malitz F and Bozzette SA: Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS Qual Life Res 1997, 6(6):531-554.
12. Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT and Hardy WD et al.: A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection Med Care 1991, 29(8):786-798.
13. Wachtel T, Piette J, Mor V, Stein M, Fleishman J and Carpenter C: Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument Ann Intern Med 1992, 116(2):129-137.
14. Wu AW, Revicki DA, Jacobson D and Malitz FE: Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) Qual Life Res 1997, 6(6):481-493.
15. Revicki DA, Sorensen S and Wu AW: Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey Med Care 1998, 36(2):126-137.
16. Ware JE Jr: SF-36 health survey update Spine 2000, 25(24):3130-3139.
17. Ware JE Jr and Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 1992, 30(6):473-483.
18. Ware JE, Snow KK, Kosinski M and Gandek B: SF-36 health survey: Manual and interpretation guide Boston (MA): The Health Institute, New England Medical Center 1993.
19. Ware J Jr, Kosinski M and Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 1996, 34(3):220-233.
20. Bing EG, Hays RD, Jacobson LP, Chen B, Gange SJ and Kass et al.: Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study Qual Life Res 2000, 9(1):55-63.
21. Copfer AE, Ampel NM, Hughes TE, Gregor KJ, Dols CL and Coons SJ et al.: The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison Qual Life Res 1996, 5(2):281-286.
22. Badia X, Podzamczer D, Garcia M, Lopez-Lavid CC and Consiglio E: A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. Spanish MOS-HIV and MQOL-HIV Validation Group. Medical Outcomes Study HIV Health Survey AIDS 1999, 13(13):1727-1735.
23. Badia X, Podzamczer D, Lopez-Lavid C and Garcia M: Evidence-based medicine and the validation of quality-of-life questionnaires: the Spanish version of the MOS-HIV questionnaire for the evaluation of the quality of life in patients infected by HIV Enferm Infecc Microbiol Clin 1999, 17(Suppl 2):103-13.
24. Badia X, Podzamczer D, Casado A, Lopez-Lavid C and Garcia M: Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV Validation Group AIDS 2000, 14(10):1439-1447.
25. Bayoumi AM and Redelmeier DA: Economic methods for measuring the quality of life associated with HIV infection Qual Life Res 1999, 8(6):471-480.
26. Burgess AP, Dayer M, Catalan J and Hawkins D: The reliability and validity of two HIV-specific health-related quality-of-life measures: A preliminary analysis AIDS 1993, 7(7):1008.
27. Carretero MD, Burgess AP, Soler P, Soler M and Catalan J: Reliability and validity of an HIV-specific health-related quality-oflife measure for use with injecting drug users AIDS 1996, 10(14):1699-1705.
28. Chan KS and Revicki DA: Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus Eval Health Prof 1998, 21(2):265-281.
29. Chatterton ML, Scott-Lennox J, Wu AW and Scott J: Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection Pharmacoeconomics 1999, 15(Suppl 1):67-74.
30. Cohen C, Revicki DA, Nabulsi A, Sarocco PW and Jiang P: A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. Advanced HIV Disease Ritonavir Study Group AIDS 1998, 12(12):1495-1502.
31. Cunningham WE, Bozzette SA, Hays RD, Kanouse DE and Shapiro MF: Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts Med Care 1995, 33(4 Suppl):AS15-AS25.
32. Delate T and Coons SJ: The discriminative ability of the 12-item short form health survey (SF-12) in a sample of persons infected with HIV Clin Ther 2000, 22(9):1112-1120.
33. Gold J, High HA, Li Y, Michelmore H, Bodsworth NJ and Finlayson R et al.: Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection AIDS 1996, 10(7):745-752.
34. Heald AE, Pieper CF and Schiffman SS: Taste and smell complaints in HIV-infected patients AIDS 1998, 12(13):1667-1674.
35. Holmes WC and Shea JA: Two approaches to measuring quality of life in the HIV/AIDS population: HAT-QoL and MOS-HIV Qual Life Res 1999, 8(6):515-527.
36. Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA and Patterson TL: Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients Med Decis Making 1997, 17(4):439-446.
37. Murri R, Ammassari A, Fantoni M, Scoppettuolo G, Cingolani A and De Luca A et al.: Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16(5):350-356.
38. Murri R, Fantoni M, Del Borgo C, Izzi I, Visona R and Suter F et al.: Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors J Acquir Immune Defic Syndr 1999, 22(5):461-466.
39. Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA and Sprangers MA: Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group AIDS 2000, 14(2):181-187.
40. O'Leary JF, Ganz PA, Wu AW, Coscarelli A and Petersen L: Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES) J Acquir Immune Defic Syndr Hum Retrovirol 1998, 17(5):433-441.
41. Raboud JM, Singer J, Thorne A, Schechter MT and Shafran SD: Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death Qual Life Res 1998, 7(6):487-494.
42. Revicki DA, Wu AW and Murray MI: Change in clinical status, health status, and health utility outcomes in HIV-infected patients Med Care 1995, 33(4 Suppl):AS173-AS182.
43. 3 Antivir Ther 1999, 4(1):35-44.
44. Revicki DA, Moyle G, Stellbrink HJ and Barker C: Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group AIDS 1999, 13(7):851-858.
45. Schag CA, Ganz PA, Kahn B and Petersen L: Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES) Qual Life Res 1992, 1(6):397-413.
46. Scott-Lennox JA, Mills RJ and Burt MS: Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life Ann Pharmacother 1998, 32(5):525-530.
47. Weinfurt KP, Willke RJ, Glick HA, Freimuth WW and Schulman KA: Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients Med Care 2000, 38(4):404-410.
48. Wu AW, Jacobson DL, Berzon RA, Revicki DA, van der HC and Fichtenbaum CJ et al.: The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS Qual Life Res 1997, 6(1):3-10.
49. Wu AW: Quality of life assessment comes of age in the era of highly active antiretroviral therapy AIDS 2000, 14(10):1451.
50. Marinacci C, Schifano P, Borgia P and Perucci CA: Application of random effect ordinal regression model for outcome evaluation of two randomized controlled trials Stat Med 2001, 20(24):3769-3776.
51. Knippels HM, Goodkin K, Weiss JJ, Wilkie FL and Antoni MH: The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscale AIDS 2002, 16(2):259-267. [erratum appears in AIDS 2002 Mar 8;16(4):681].
52. Miners AH, Sabin CA, Mocroft A, Youle M, Fisher M and Johnson M: Health-related quality of life in individuals infected with HIV in the era of HAART HIV Clin Trials 2001, 2(6):484-492.
53. Casado A, Consiglio E, Podzamczer D and Badia X: Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients HIV Clin Trials 2001, 2(6):477-483.
54. Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M and Markstein L et al.: Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection AIDS Patient Care and STDs 2001, 15(12):615-624.
55. Piketty C, Jayle D, Leplege A, Castiel P, Ecosse E and Gonzalez-Canali G et al.: Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease Clin Endocrinol 2001, 55(3):325-330.
56. Blanch J, Martinez E, Rousaud A, Blanco JL, Garcia-Viejo MA and Peri JM et al.: Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz J Acquir Immune Defic Syndr 2001, 27(4):336-343.
57. Scott-Lennox JA, Wu AW, Boyer JG and Ware JE Jr: Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey Med Care 1999, 37(9):908-925.
58. Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP and DeMasi RA et al.: Health-related quality of life and virologic outcomes in an HIV clinic Qual Life Res 2000, 9(9):977-985.
59. Anderson JP, Kaplan RM, Coons SJ and Schneiderman LJ: Comparison of the Quality of Well-being Scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses J Clin Epidemiol 1998, 51(9):755-762.
60. Arpinelli F, Visona G, Bruno R, De Carli G and Apolone G: Health-related quality of life in asymptomatic patients with HIV. Evaluation of the SF-36 health survey in Italian patients Pharmacoeconomics 2000, 18(1):63-72.
61. Bakken S, Holzemer WL, Brown MA, Powell-Cope GM, Turner JG and Inouye J et al.: Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS AIDS Patient Care and STDS 2000, 14(4):189-197.
62. Bastardo YM and Kimberlin CL: Relationship between quality of life, social support and disease-related factors in HIV-infected persons in Venezuela AIDS Care 2000, 12(5):673-684.
63. Bult JR, Hunink MG, Tsevat J and Weinstein MC: Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patients Med Care 1998, 36(4):523-532.
64. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Ebrahim S and Lee CA: Assessing health-related quality-of-life in patients with severe haemophilia A and B Psychology, Health & Medicine 1999, 4(1):15.
65. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P and Lee CA: Assessing health-related quality-of-life in individuals with haemophilia Haemophilia 1999, 5(6):378-385.
66. O'Keefe EA and Wood R: The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population Qual Life Res 1996, 5(2):275-280.
67. Swindells S, Mohr J, Justis JC, Berman S, Squier C and Wagener MM et al.: Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness Int J STD AIDS 1999, 10(6):383-391.
68. Tsevat J, Solzan JG, Kuntz KM, Ragland J, Currier JS and Sell RL et al.: Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning Med Care 1996, 34(1):44-57.
69. Burgoyne RW and Saunders DS: Quality of life among urban Canadian HIV/AIDS clinic outpatients Int J of STD AIDS 2001, 12(8):505-512.
70. te Vaarwerk MJ and Gaal EA: Psychological distress and quality of life in drug-using and non-drug-using HIV-infected women Eur J Public Health 2001, 11(1):109-115.
71. IQOLA Project SF-36 and SF-12 Translations [http://www.qualitymetric.com/cgi-bin/license/lang/matrix.cgi?i=0]
72. Lamping DL: Measuring quality of life in HIV infection: validation of the SF-36 short-form health survey Int Conf AIDS 1993, 9(2):780.
73. Delate T and Coons SJ: The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus Clin Infect Dis 2001, 32(3):e47-e52.
74. Hays RD, Cunningham WE, Sherbourne CD, Wilson IB, Wu AW and Cleary PD et al.: Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study Am J Med 2000, 108(9):714-722.
75. Ware JE, Kosinski M and Keller SD: SF-36 Physical and Mental Health Summary Scales: A User's Manual Boston (MA): The Health Institute, New England Medical Center 1994.
76. Wu AW, Rubin HR, Bozzette SA, Mathews WC, Snyder R and Wright B et al.: A longitudinal study of quality of life in asymptomatic HIV infection Int Conf AIDS 1991, 7(1):348.
77. Singer J, Thorne A, Khorasheh S, Raboud JM, Wu AW and Salit I et al.: Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group Int J STD AIDS 2000, 11(4):212-219.
78. Bindman AB, Keane D and Lurie N: Measuring health changes among severely ill patients. The floor phenomenon Med Care 1990, 28(12):1142-1152.
79. Panel on Clinical Practices for Treatment of HIV Infection et al.: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. [http://www.aidsinfo.nih.gov/guidelines/adult/AA_071403.pdf].
80. Gallant S, Ricciardi P, Sudre P, Kruseman M, von Overbeck J and Burnand B et al.: Health status: use of the French MOS-SF-40 in HIV + patients Int Conf AIDS 1996, 11(1):323.
81. Gerbaud L, Laurichesse H, Biolay S, Gourdon F, Marcombes V and Glanddier PY et al.: Health related quality of life among HIV patients - preliminary results of a prospective study Int Conf AIDS 1996, 11(2):116.